There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
"As a result, the company's balance sheet remains strong, including a record level of cash. After the anticipated close of the merger with Johnson & Johnson, we will be even better prepared to tackle emerging trends in the changing healthcare...
16 (Bloomberg) -- Johnson & Johnson and the University of Queensland will co-develop drugs using components of spider venom as a treatment for chronic pain. The maker of Ultram painkillers will work with Queensland’s Institute of Molecular Bioscience...
This Jan. 22, 2012 photo shows Johnson & Johnson bath products for sale on a store shelf, in Springfield, Ill. Johnson & Johnson said Tuesday that fourth-quarter profit was barely a tenth what it made a year ago as a slew of charges for recalls,... View Photo »
They lost their son. They want justice. Johnson & Johnson says one thing and does another
Corp. , and Venrock Associates—also participated in the round. The company was founded in 2000, and a recent article in Dow Jones VentureWire said Celladon had raised more than $56.3 million by 2009 from investors that included Enterprise Partners...
I don’t wear mascara often. The lip product I’m currently wearing is LUSH’s Honey Trap I love this stuff! It lasts for ever on my lips! The only skin care I’ve used today is Cetaphil to wash my face in the morning, and then I applied some Johnson &...
William C. Weldon, chairman and CEO of Johnson & Johnson, participates in the APEC CEO Summit in Honolulu, Hawaii November 12, 2011. View Photo »
We call on the remaining three companies we have invited to the table—Abbott, Merck, and Johnson & Johnson—to also enter into negotiations with the Pool.
I have scoured to find four companies that pay a dividend rate of at least 150% of the 10 year Treasury yield, and have at least a 50 year history of annual dividend increases. Finally, I have looked for companies that do not have the wide institutional...
Joseph also established and grew his own marketing services agency (CPPartners), sold to Publicis in 2002, that serviced a range of clients including Tylenol, Kellogg's, Cadillac, American Express and Pfizer. Prior to Publicis Groupe, Joseph held...
Johnson & Johnson (NYSE: JNJ) is a global American pharmaceutical, medical devices and consumer packaged goods manufacturer founded in 1886. Its common stock is a component of the Dow Jones Industrial Average and the company is listed among the Fortune 500. Johnson & Johnson is known for its corporate reputation,[citation needed] consistently... Full Article
William C. Weldon, chairman and CEO of Johnson & Johnson, participates in the APEC CEO Summit in Honolulu, Hawaii November 12, 2011.
View Photo »WAIKIKI, HI - NOVEMBER 12: Panel member Johnson & Johnson CEO William Weldon and journalist Patricia Janot take part in panel discussion Redefining Health: An Economic Asset and Competitive Advantage at the APEC CEO Summit 2001 meeting, part of the Asia-Pacific Economic Cooperation...
View Photo »Johnson & Johnson CEO William Weldon speaks during the CEO Summit at the Asia-Pacific Economic Cooperation (APEC) summit in Honolulu, Hawaii, on November 12, 2011. The United States is hosting this year's APEC forum for the first time since 1993, with leaders from the 21 member...
View Photo »Band-Aid products, made by Johnson & Johnson, are seen in a store in Brunswick, Maine, on Tuesday, Oct. 18, 2011. Johnson & Johnson's third-quarter profit fell 6 percent because larger overhead and production costs and a one-time charge offset higher foreign sales.
View Photo »Dr. Scott Ratzan, vice president of Global Health of Johnson & Johnson speaks during a discussion regarding initiatives to combat non-communicable diseases at the Clinton Global Initiative in New York, September 21, 2011.
View Photo »SUN VALLEY, ID - JULY 09: William 'Bill' Weldon, chief executive of Johnson & Johnson, attends the Allen & Company Media and Technology Conference on July 9, 2011 in Sun Valley, Idaho. The conference has been hosted annually by the investment firm Allen & Company each July since 1983. ...
View Photo »This undated image provided by Johnson & Johnson shows the CYPHER Sirolimus-eluting Coronary Stent. Johnson & Johnson said Wednesday, June 15, 2011 it will stop making and developing heart stents to focus on other stent types, a case of the pioneer in effect ceding that territory of the...
View Photo »NEW YORK, NY - JUNE 14: Akilah Peynado (L), a job recruiter with Johnson & Johnson, speaks with an attendee at the New York Sales Career Fair on June 14, 2011 in New York City. As mixed signals continue to emerge about the health of the US economy, reports show that US employers have...
View Photo »From left: Sarah Colamarino, Johnson & Johnson, Judy Meehan, National Healthy Mothers, Healthy Babies Coalition, and Stacie Paxton, Hill & Knowlton.
View Photo »WAIKIKI, HI - NOVEMBER 12: Panel members Yasuchika Hasegawa, (L) President & CEO of Takeda Pharmaceutical Company Limited and Johnson & Johnson CEO William Weldon and Journalist Patricia Janot take part in panel discussion Redefining Health: An Economic Asset and Competitive Advantage...
View Photo »WAIKIKI, HI - NOVEMBER 12: Panel members from left to right Dr. Toby Cosgrove, CEO of The Cleveland Clinic, Yasuchika Hasegawa, President & CEO of Takeda Pharmaceutical Company Limited and Johnson & Johnson CEO William Weldon and Journalist Patricia Janot take part in panel discussion...
View Photo »U.S. APEC Business Coalition members including Thomas J. Donohue, President and CEO, U.S. Chamber of Commerce, (L-R), William Weldon, Chairman and CEO of Johnson & Johnson, and John S. Chen, Chairman, CEO & President, Sybase, Inc. , attend a meeting with President Hu Jintao, President of...
View Photo »U.S. APEC Business Coalition members including Thomas J. Donohue, President and CEO, U.S. Chamber of Commerce, left to right:, William Weldon, Chairman and CEO of Johnson & Johnson, John S. Chen, Chairman, CEO & President, Sybase, Inc. , William V. Hickey, CEO of Sealed Air Corporation,...
View Photo »COMMERCIAL IMAGE - In this photograph taken by AP Images for AIDS Healthcare Foundation, Protestors from the AIDS Healthcare Foundation deliver a bag full of petitions requesting lower AIDS drug pricing to Johnson & Johnson headquarters in New Brunswick, NJ on Wednesday, Nov. 2, 2011.
View Photo »FILE - In this Oct. 18, 2011 file photo, First Aid products made by Johnson & Johnson, are displayed in a store in Brunswick, Maine. Johnson & Johnson announced Tuesday, Jan. 24, 2012, sales of $16.3 billion for the fourth quarter of 2011, an increase of 3.9% as compared to the fourth...
View Photo »COMMERCIAL IMAGE - In this photograph taken by AP Images for the AIDS Healthcare Foundation, protesters from the AIDS Healthcare Foundation stage a "die-in" at Johnson & Johnson headquarters in New Brunswick, NJ on Friday, Sept. 30, 2011.
View Photo »COMMERCIAL IMAGE - In this photo taken by AP Images for the AIDS Healthcare Foundation, AIDS Healthcare Foundation protesters march at Johnson & Johnson Headquarters Tuesday, August 17, 2011 in New Brunswick NJ.
View Photo »Merrian Brooks, a fourth year medical student at Ohio University, holds up a sign as she protests outside of the Johnson & Johnson shareholders meeting, Thursday, April 28, 2011 in New Bruinswick, N.J. Members of PETA are also seen protesting outside of the Hyatt Regency Hotel.
View Photo »This undated photo provided by Boston Scientific Corp. , shows Michael Mahoney who will appointed president of Boston Scientific Corp. , Oct. 17, 2011. Boston Scientific Corp.'s choice of Johnson & Johnson executive Michael Mahoney to become its next leader drew praise from analysts...
View Photo »Swiss medical device company Synthes Chairman of the board Hansjoerg Wyss (L) and his daughter Amy attend the general shareholders meeting in Solothurn April 28, 2011. Johnson & Johnson is to buy Synthes Inc in a deal worth $21.3 billion, its largest ever buy, boosting its orthopaedics...
View Photo »Swiss medical device company Synthes Chairman of the board Hansjoerg Wyss speaks during the general shareholders meeting in Solothurn April 28, 2011. Johnson & Johnson is to buy Synthes Inc in a deal worth $21.3 billion, its largest ever buy, boosting its orthopaedics franchise and...
View Photo »A general view shows the headquarters of Swiss medical devices maker Synthes in Oberdorf April 25, 2011. Johnson & Johnson is to buy Synthes Inc for 19 billion Swiss francs ($21.59 billion) in its largest ever buy, boosting its orthopaedic business and reshaping the wider industry, the...
View Photo »Flags fly in front of the headquarters of Swiss medical devices maker Synthes in Oberdorf April 25, 2011. Johnson & Johnson is to buy Synthes Inc for 19 billion Swiss francs ($21.59 billion) in its largest ever buy, boosting its orthopaedic business and reshaping the wider industry,...
View Photo »The company logo of Swiss medical devices maker Synthes is pictured in front of it headquarters in Oberdorf April 25, 2011. Johnson & Johnson is to buy Synthes Inc in a deal worth $21.3 billion, its largest ever buy, boosting its orthopaedics franchise and reshaping the medical...
View Photo »A general view shows Swiss medical devices maker Synthes' headquarters in Oberdorf, April 25, 2011. Johnson & Johnson is to buy Synthes Inc in a deal worth $21.3 billion, its largest ever buy, boosting its orthopaedics franchise and reshaping the medical technology industry. Picture...
View Photo »William C. Weldon, chairman and CEO of Johnson & Johnson, participates in the APEC CEO Summit in Honolulu, Hawaii November 12, 2011.
View Photo »They lost their son. They want justice. Johnson & Johnson says one thing and does another
We call on the remaining three companies we have invited to the table—Abbott, Merck, and Johnson & Johnson—to also enter into negotiations with the Pool.
The case often cited is the (1982) Tylenol poisoning case. Even though the maker had no direct connection to the poisoning, it responded in an open fashion with a massive recall. Many people say that over-response is an example of how (Tylenol maker Johnson & Johnson) built a perception of responsibilit...
Johnson & Johnson baby products will no longer include phthlates, quaternium-15, and reduce exposure to 1,4 dioxane. But they’ll still be a long way from natural, with ingredients like parabens on their labels.
DePuy and Johnson & Johnson must accept full responsibility for the lost wages and income, medical expenses, and pain and suffering incurred by patients whose ASR hip implant has failed.
Bapineuzumab A beta amyloid inhibitor for the treatment of Alzheimer's disease being developed in collaboration with Janssen Alzheimer Immunotherapy Research & Development, LLC (Janssen AI), a subsidiary of Johnson & Johnson
It was through the lens of Pfizer and Johnson & Johnson that the industrywide probe got going
By then his advertisers were, like, that company that asks you to send them your gold for cash or the makers of home face-lifts ... Not McDonald's or Johnson & Johnson.
